کوواکسین (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "کوواکسین" in Persian language version.

refsWebsite

Global rank Persian rank

4indianexpress.com

60^th place

323^rd place

4doi.org

2^nd place

3livemint.com

390^th place

4,546^th place

3thehindu.com

52^nd place

851^st place

2theprint.in

987^th place

low place

2hindustantimes.com

71^st place

249^th place

1nytimes.com

7^th place

24^th place

1ddnews.gov.in

low place

1washingtonpost.com

34^th place

90^th place

1medrxiv.org

low place

1web.archive.org

1^st place

1thelancet.com

2,393^rd place

5,046^th place

1clinicaltrials.gov

5,225^th place

5,710^th place

1ndtv.com

138^th place

611^th place

1deccanherald.com

516^th place

2,897^th place

1nih.gov

4^th place

5^th place

1businesstoday.in

1,332^nd place

8,837^th place

1newindianexpress.com

188^th place

3,087^th place

1reuters.com

49^th place

76^th place

1indiatimes.com

17^th place

139^th place

1bbc.com

20^th place

3^rd place

1thewire.in

1,507^th place

low place

bbc.com

"Coronavirus: India approves vaccines from Bharat Biotech and Oxford/AstraZeneca". BBC News (به انگلیسی). 2021-01-03. Retrieved 2021-01-03.

businesstoday.in

"Coronavirus vaccine update: Bharat Biotech's Covaxin launch likely in Q2 of 2021, no word on pricing yet". www.businesstoday.in. India Today Group. Retrieved 13 December 2020.

clinicaltrials.gov

"An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers". clinicaltrials.gov (Registry). United States National Library of Medicine. NCT04641481. Retrieved 2020-11-26.

ddnews.gov.in

"Human clinical trials of potential Covid-19 vaccine 'COVAXIN' started at AIIMS". DD News. Prasar Bharati, Ministry of I & B, Government of India. 25 July 2020.

deccanherald.com

"Covaxin phase-3 trials to end today, average efficacy 60-70%". Deccan Herald. 5 January 2021.

doi.org

Ella, Raches; Mohan, Krishna; Jogdand, Harsh; Prasad, Sai; Reddy, Siddharth; Sarangi, Vamshi Krishna; Ganneru, Brunda; Sapkal, Gajanan; Yadav, Pragya; Panda, Samiran; Gupta, Nivedita; Reddy, Prabhakar; Verma, Savita; Rai, Sanjay; Singh, Chandramani; Redkar, Sagar; Gillurkar, Chandra Sekhar; Kushwaha, Jitendra Singh; Rao, Venkat; Mohapatra, Satyajit; Guleria, Randeep; Ella, Krishna; Bhargava, Balram (15 December 2020). "Safety and immunogenicity trial of an inactivated SARS-CoV-2 vaccine-BBV152: a phase 1, double-blind, randomised control trial". medRxiv (به انگلیسی). doi:10.1101/2020.12.11.20210419.
Ella, Raches; Vadrevu, Krishna Mohan; Jogdand, Harsh; Prasad, Sai; Reddy, Siddharth; Sarangi, Vamshi; Ganneru, Brunda; Sapkal, Gajanan; Yadav, Pragya; Abraham, Priya; Panda, Samiran; Gupta, Nivedita; Reddy, Prabhakar; Verma, Savita; Rai, Sanjay Kumar; Singh, Chandramani; Redkar, Sagar Vivek; Gillurkar, Chandra Sekhar; Kushwaha, Jitendra Singh; Mohapatra, Satyajit; Rao, Venkat; Guleria, Randeep; Ella, Krishna; Bhargava, Balram (21 January 2021). "Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial". The Lancet Infectious Diseases (به انگلیسی). doi:10.1016/S1473-3099(20)30942-7.
Ganneru B, Jogdand H, Daram VK, Molugu NR, Prasad SD, Kannappa SV, et al. (9 September 2020). "Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion InactivatedSARS-CoV-2 Vaccine - BBV152". doi:10.1101/2020.09.09.285445. {{cite journal}}: Cite journal requires |journal= (help)
Hoeksema F, Karpilow J, Luitjens A, Lagerwerf F, Havenga M, Groothuizen M, et al. (April 2018). "Enhancing viral vaccine production using engineered knockout vero cell lines - A second look". Vaccine. 36 (16): 2093–2103. doi:10.1016/j.vaccine.2018.03.010. PMID 29555218.

hindustantimes.com

Sabarwal, Harshit (16 December 2020). "Covaxin's phase 1 trial result shows robust immune response, mild adverse events". Hindustan Times (به انگلیسی). Archived from the original on 16 December 2020. Retrieved 17 December 2020.
Ghosh N (7 December 2020). "Bharat Biotech seeks emergency use authorization for Covid-19 vaccine". Hindustan Times (به انگلیسی).

indianexpress.com

"Delhi: 30-year-old is first to get dose of trial drug Covaxin". The Indian Express (به انگلیسی). 25 July 2020.
"Bharat Biotech begins Covaxin Phase III trials". The Indian Express (به انگلیسی). 18 November 2020.
Raghavan P (24 September 2020). "Bharat Biotech exploring global tie-ups for Covaxin manufacturing". The Indian Express (به انگلیسی).
"Expert panel recommends granting approval for restricted emergency use of Bharat Biotech's Covaxin". The Indian Express (به انگلیسی). 2 January 2021.

indiatimes.com

economictimes.indiatimes.com

"Bharat Biotech, Ocugen to co-develop Covaxin for US market". The Economic Times. Retrieved 2021-01-05.

livemint.com

"ICMR teams up with Bharat Biotech to develop Covid-19 vaccine". Livemint (به انگلیسی). 9 May 2020.
Sen M (2 December 2020). "List of states that have started phase 3 trials of India's first Covid vaccine". mint (به انگلیسی).
"Bharat Biotech inks pact with Precisa Med to supply Covaxin to Brazil". mint (به انگلیسی). 12 January 2021.

medrxiv.org

Ella, Raches; Mohan, Krishna; Jogdand, Harsh; Prasad, Sai; Reddy, Siddharth; Sarangi, Vamshi Krishna; Ganneru, Brunda; Sapkal, Gajanan; Yadav, Pragya; Panda, Samiran; Gupta, Nivedita; Reddy, Prabhakar; Verma, Savita; Rai, Sanjay; Singh, Chandramani; Redkar, Sagar; Gillurkar, Chandra Sekhar; Kushwaha, Jitendra Singh; Rao, Venkat; Mohapatra, Satyajit; Guleria, Randeep; Ella, Krishna; Bhargava, Balram (15 December 2020). "Safety and immunogenicity trial of an inactivated SARS-CoV-2 vaccine-BBV152: a phase 1, double-blind, randomised control trial". medRxiv (به انگلیسی). doi:10.1101/2020.12.11.20210419.

ndtv.com

"70%-80% Drop In Participation For Phase 3 Trials Of Covaxin: Official". NDTV. 17 December 2020.

newindianexpress.com

"Odisha fast tracks coronavirus vaccine manufacturing unit". The New Indian Express. 7 November 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Hoeksema F, Karpilow J, Luitjens A, Lagerwerf F, Havenga M, Groothuizen M, et al. (April 2018). "Enhancing viral vaccine production using engineered knockout vero cell lines - A second look". Vaccine. 36 (16): 2093–2103. doi:10.1016/j.vaccine.2018.03.010. PMID 29555218.

nytimes.com

"India's First COVID-19 Vaccine Candidate Approved for Human Trials". The New York Times. 29 June 2020.

reuters.com

Reuters Staff (2020-12-22). "Ocugen to co-develop Bharat Biotech's COVID-19 vaccine candidate for U.S." Reuters (به انگلیسی). Retrieved 2021-01-05.

thehindu.com

Perappadan, Bindu Shajan (16 December 2020). "Coronavirus | Covaxin phase-1 trial results show promising results". The Hindu (به انگلیسی). Retrieved 17 December 2020.
"Coronavirus | Covaxin Phase III trial from November". The Hindu (به انگلیسی). 23 October 2020.
"Coronavirus | After SII, Bharat Biotech seeks DCGI approval for Covaxin". The Hindu (به انگلیسی). 7 December 2020.

thelancet.com

Ella, Raches; Vadrevu, Krishna Mohan; Jogdand, Harsh; Prasad, Sai; Reddy, Siddharth; Sarangi, Vamshi; Ganneru, Brunda; Sapkal, Gajanan; Yadav, Pragya; Abraham, Priya; Panda, Samiran; Gupta, Nivedita; Reddy, Prabhakar; Verma, Savita; Rai, Sanjay Kumar; Singh, Chandramani; Redkar, Sagar Vivek; Gillurkar, Chandra Sekhar; Kushwaha, Jitendra Singh; Mohapatra, Satyajit; Rao, Venkat; Guleria, Randeep; Ella, Krishna; Bhargava, Balram (21 January 2021). "Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial". The Lancet Infectious Diseases (به انگلیسی). doi:10.1016/S1473-3099(20)30942-7.

theprint.in

Chakrabarti A (10 May 2020). "India to develop 'fully indigenous' Covid vaccine as ICMR partners with Bharat Biotech". ThePrint.
"Bharat Biotech's Covaxin given conditional nod based on incomplete Phase 3 trial results data". The Print. 3 January 2021.

thewire.in

science.thewire.in

"Disputes Mount, but Heedless Govt Intent on Rolling Vaccine Candidates Out". The Wire. 12 January 2021.

washingtonpost.com

Press, Associated (25 July 2020). "Asia Today: Amid new surge, India tests potential vaccine". Washington Post. Retrieved 17 December 2020.

web.archive.org

Sabarwal, Harshit (16 December 2020). "Covaxin's phase 1 trial result shows robust immune response, mild adverse events". Hindustan Times (به انگلیسی). Archived from the original on 16 December 2020. Retrieved 17 December 2020.